JEOL Ltd
TSE:6951
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4 406
7 403
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
JEOL Ltd
JEOL Ltd
Income from Continuing Operations
JEOL Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
JEOL Ltd
TSE:6951
|
Income from Continuing Operations
¥25.1B
|
CAGR 3-Years
66%
|
CAGR 5-Years
34%
|
CAGR 10-Years
20%
|
|
|
Terumo Corp
TSE:4543
|
Income from Continuing Operations
¥119.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
|
|
Olympus Corp
TSE:7733
|
Income from Continuing Operations
¥87.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Sysmex Corp
TSE:6869
|
Income from Continuing Operations
¥53.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Nihon Kohden Corp
TSE:6849
|
Income from Continuing Operations
¥9.5B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Nakanishi Inc
TSE:7716
|
Income from Continuing Operations
¥8.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
JEOL Ltd
Glance View
In the bustling world of advanced scientific instrumentation, JEOL Ltd. has carved a distinguished niche for itself as a renowned innovator from the Land of the Rising Sun. Founded in 1949, this Japanese trailblazer has unfurled an impressive tapestry of technological advancements in electron optics and analytical instruments. With its headquarters nestled in Tokyo, JEOL has been at the forefront of developing sophisticated tools such as scanning electron microscopes, nuclear magnetic resonance spectrometers, and mass spectrometers. These instruments have become indispensable for scientists and researchers across myriad fields, ranging from materials science to biotechnology. By focusing on high-quality precision and cutting-edge innovation, JEOL's products aid in unveiling the microscopic secrets of the world, empowering its users to explore realms of science once thought unreachable. What sets JEOL apart is its commitment not just to the science of today but to the possibilities of tomorrow. The company has consistently reinvested its profits into research and development, fostering a culture of perpetual innovation. By maintaining a comprehensive global sales and support network, JEOL ensures that its instruments are not only technologically advanced but also accessible to a worldwide clientele. This business model is reflective of their ability to generate revenue through both direct sales and ongoing service and support contracts, ensuring a steady revenue stream while bolstering relationships with research institutions, universities, and industries worldwide. Through this multifaceted approach, JEOL sustains its financial health, while solidifying its reputation as a catalyst for scientific discovery and technological progress.
See Also
What is JEOL Ltd's Income from Continuing Operations?
Income from Continuing Operations
25.1B
JPY
Based on the financial report for Sep 30, 2024, JEOL Ltd's Income from Continuing Operations amounts to 25.1B JPY.
What is JEOL Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
20%
Over the last year, the Income from Continuing Operations growth was 39%. The average annual Income from Continuing Operations growth rates for JEOL Ltd have been 66% over the past three years , 34% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
